Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Renal-type clear cell carcinoma of prostate: A case report and review of literature.

  • Authors : Liao G; Department of Pathology, Red Cross Hospital of Yulin, Yulin, China.; Zhang X

Subjects: Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*diagnosis ; Kidney Neoplasms/Kidney Neoplasms/Kidney Neoplasms/*diagnosis ; Prostate/Prostate/Prostate/*pathology

  • Source: Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2018 Jul-Sep; Vol. 61 (3), pp. 431-433.Publisher: Medknow Country of Publication: India NLM ID: 7605904 Publication Model: Print Cited Medium: Internet ISSN: 0974-5130 (Electronic)

Record details

×
Academic Journal

Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.

  • Authors : Zhang K; Department of Radiology, PLA General Hospital, Beijing, China.; Department of Radiology, Navy General Hospital, Beijing, China.

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; Prostate/Prostate/Prostate/*pathology ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*diagnosis

  • Source: PloS one [PLoS One] 2016 Mar 10; Vol. 11 (3), pp. e0151176. Date of Electronic Publication: 2016 Mar 10 (Print Publication: 2016).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.

  • Authors : Barber NJ; Department of Urology, Frimley Park Hospital, Surrey, UK. ; Zhang X

Subjects: Anticarcinogenic Agents/Anticarcinogenic Agents/Anticarcinogenic Agents/*pharmacology ; Carotenoids/Carotenoids/Carotenoids/*pharmacology ; DNA, Neoplasm/DNA, Neoplasm/DNA, Neoplasm/*biosynthesis

  • Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2006; Vol. 9 (4), pp. 407-13. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence.

  • Authors : Liu C; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Photothermal Therapy*/Photothermal Therapy*/Photothermal Therapy*/methods ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 03; Vol. 22 (1), pp. 224. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

×
Academic Journal

Identification and functional activity of Nik related kinase (NRK) in benign hyperplastic prostate.

  • Authors : He W; Department of Urology, Xijing Hospital of Air Force Medical University, West Changle Road 127, Xi'an, China. .; Tian Z

Subjects: Prostate*/Prostate*/Prostate*/metabolism ; Prostatic Hyperplasia*/Prostatic Hyperplasia*/Prostatic Hyperplasia*/genetics ; Prostatic Hyperplasia*/Prostatic Hyperplasia*/Prostatic Hyperplasia*/metabolism

  • Source: Journal of translational medicine [J Transl Med] 2024 Mar 09; Vol. 22 (1), pp. 255. Date of Electronic Publication: 2024 Mar 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

  • Authors : Chen N; Department of Urology, Meizhou People's Hospital, Meizhou 514089, China.; Wang Z

Subjects: Goserelin*/Goserelin*/Goserelin*/adverse effects ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy; Male

  • Source: Cancer biology & medicine [Cancer Biol Med] 2024 Feb 05; Vol. 20 (12).Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer.

  • Authors : Wang J; Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, 832000, Xinjiang, China.; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, 832000, Xinjiang, China.

Subjects: Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Animals

  • Source: BMC cancer [BMC Cancer] 2024 Jan 15; Vol. 24 (1), pp. 75. Date of Electronic Publication: 2024 Jan 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Chrysosplenol D can inhibit the growth of prostate cancer by inducing reactive oxygen species and autophagy.

  • Authors : Zhang H; Department of Urology, The Second People's Hospital of Kunshan, Kunshan, Jiangsu, China.; You Z

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Humans

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Oct; Vol. 11 (10), pp. e1061.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development of [ 177 Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.

  • Authors : Wen X; State Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of PublicHealth, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.; Xu P

Subjects: Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism; Male

  • Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (9), pp. 2846-2860. Date of Electronic Publication: 2023 Apr 25.Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis.

  • Authors : Ye X; School of Medicine, Southern University of Science and Technology, No. 1088 Xue Yuan Blvd, Shenzhen, 518055, Guangdong, China.; Huang X

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/metabolism; Humans

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2023 May 03; Vol. 16 (1), pp. 46. Date of Electronic Publication: 2023 May 03.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

Record details

×
  • 1-10 of  116 results for ""Zhang X""